Salt Lake City, Utah; Nashville, Tenn.; Garden City and Valhalla, N.Y.; Detroit, Mich.; and Bala Cynwyd, Pa.
From the Division of Plastic Surgery, University of Utah, Huntsman Cancer Institute; the Department of Plastic Surgery, Vanderbilt University Medical Center; Long Island Plastic Surgery Group PC; the Henry Ford Health System; the Westchester Medical Center, New York Medical College; and Drexel University College of Medicine.
Received for publication January 19, 2018; accepted May 22, 2018.
This trial is registered under the name “Feasibility Study of Meso BioMatrix Device for Breast Reconstruction,” ClinicalTrials.gov identification number NCT01823107.
Disclosure:This is an industry-initiated trial sponsored by DSM Biomedical (Exton, Pa.). The manuscript was written by the authors without sponsor oversight, interference, or approval. Dr. Simpson received travel reimbursement to attend a meeting with the study monitors to evaluate the results of the final study report. Dr. Kilgo was an investigator on NCT01256502, sponsored by Sofregen Medical, Inc. (Medford, Mass.). The authors have no other commercial conflicts of interest to disclose related to the contents of this article. No direct or indirect funding was received for this article.
Jayant P. Agarwal, M.D., Division of Plastic and Reconstructive Surgery, University of Utah, School of Medicine, 30 North 1900 E, 3B400, Salt Lake City, Utah 84132, [email protected]
